EVARREST Fibrin Sealant Patch

EVARREST® Fibrin Sealant Patch

The EVARREST® Fibrin Sealant Patch from Ethicon, part of the Johnson & Johnson family of companies, uses human biologics—thrombin and fibrinogen—to create a structure for clot formation to stop bleeding. In December 2012, FDA granted approval for the product’s adjunctive use in specific surgical cases, including open retroperitoneal, intra-abdominal, pelvic, and non-cardiac thoracic surgeries. The agency broadened that indication in October 2016 to cover adjunctive use for general hemostasis in surgeries on adult patients.

The product was a gold winner in the 2015 Medical Design Excellence Awards in the category of Drug-Delivery Devices and Combination Products.

             

[Image courtesy of ETHICON]

Register for the MD&M Minneapolis Conference and Expo, November 8-9.

 

Device talk Tags: